Discontinued — last reported Q3 '25
Atlassian Equity Method Investments increased by 2.8% to $55.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.0%, from $50.81M to $55.39M. Over 3 years (FY 2022 to FY 2025), Equity Method Investments shows a downward trend with a -25.2% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $127.00M | $88.85M | $87.78M | $86.37M | $85.44M | $76.28M | $80.75M | $72.78M | $74.51M | $61.72M | $55.44M | $50.81M | $53.12M | $53.45M | $53.89M | $55.39M |
| QoQ Change | — | -30.0% | -1.2% | -1.6% | -1.1% | -10.7% | +5.9% | -9.9% | +2.4% | -17.2% | -10.2% | -8.3% | +4.5% | +0.6% | +0.8% | +2.8% |
| YoY Change | — | — | — | — | -32.7% | -14.1% | -8.0% | -15.7% | -12.8% | -19.1% | -31.3% | -30.2% | -28.7% | -13.4% | -2.8% | +9.0% |